In non-small cell lung cancer, METTL3 may promote the development of the disease by facilitating the maturation of pri-miR-21-5p, upregulating miR-21-5p, and targeting the inhibition of FDX1 (Qian et al., 2023). The gene discussed is FDX1; the disease is non-small cell lung carcinoma.